Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Lung Neoplasms and CYP3A[original query] |
|---|
| The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. Pharmacogenetics 2003 Oct 13 (10): 607-18. Dally Heike, Edler Lutz, Jäger Birgit, Schmezer Peter, Spiegelhalder Bertold, Dienemann Hendrik, Drings Peter, Schulz Volker, Kayser Klaus, Bartsch Helmut, Risch Ange |
| Genotype relationships in the CYP3A locus in Caucasians. Cancer letters 2004 Apr 207 (1): 95-9. Dally Heike, Bartsch Helmut, Jäger Birgit, Edler Lutz, Schmezer Peter, Spiegelhalder Bertold, Dienemann Hendrik, Drings Peter, Kayser Klaus, Schulz Volker, Risch Ange |
| Significance of the minor cytochrome P450 3A isoforms. Clinical pharmacokinetics 2006 1 45 (1): 13-31. Daly Ann |
| Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses. Clinical pharmacology and therapeutics 2014 Aug 96 (2): 182-91. Phelps M A, Stinchcombe T E, Blachly J S, Zhao W, Schaaf L J, Starrett S L, Wei L, Poi M, Wang D, Papp A, Aimiuwu J, Gao Y, Li J, Otterson G A, Hicks W J, Socinski M A, Villalona-Calero M |
| Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. Cancer research 2016 Mar 76 (6): 1485-93. Johnson Nichola, De Ieso Paolo, Migliorini Gabriele, Orr Nick, Broderick Peter, Catovsky Daniel, Matakidou Athena, Eisen Timothy, Goldsmith Christy, Dudbridge Frank, Peto Julian, Dos-Santos-Silva Isabel, Ashworth Alan, Ross Gillian, Houlston Richard S, Fletcher Oliv |
| Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin. British journal of clinical pharmacology 2018 Sep . Harvey R Donald, Aransay Noemi Reguart, Isambert Nicolas, Lee Jong-Seok, Arkenau Tobias, Vansteenkiste Johan, Dickinson Paul A, Bui Khanh, Weilert Doris, So Karen, Thomas Karen, Vishwanathan Karthi |
| Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir. The pharmacogenomics journal 2021 3 21 (3): 336-345. van Eijk Maarten, Pluim Dick, Dorlo Thomas P C, Marchetti Serena, Huitema Alwin D R, Beijnen Jos |
| Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant. European journal of clinical pharmacology 2022 1 78 (4): 613-621. Hibino Hideyuki, Sakiyama Naomi, Makino Yoshinori, Makihara-Ando Reiko, Horinouchi Hidehito, Fujiwara Yutaka, Kanda Shintaro, Goto Yasushi, Yoshida Tatsuya, Okuma Yusuke, Shinno Yuki, Murakami Shuji, Hashimoto Hironobu, Akiyoshi Takeshi, Imaoka Ayuko, Ohe Yuichiro, Yamaguchi Masakazu, Ohtani Hisaka |
- Page last reviewed:Feb 1, 2024
- Content source:

